• Profile
Close

A comparison of two intravesical bladder instillations for interstitial cystitis/bladder pain syndrome

European Journal of Obstetrics & Gynecology and Reproductive Biology Nov 04, 2020

Keane J, Young N, Goh J, et al. - Researchers assumed that iAluRil (a GAG therapy) would demonstrate equivalent symptom, pain, and QOL scores compared to DMSO controls. They administered iAluRil for 7 instillations over 3 months in 34 women over 6 sites. They matched 18 historical DMSO controls in a 2:1 ratio. The post-treatment validated questionnaires were collected at baseline and 3 months. The results revealed that iAluRil is well tolerated and associated with significant improvements in pain and symptom scores. The data demonstrate that almost half of the refractory bladder pain syndrome will have a 50% decrease in pain score at three months post-treatment. It was noted that this effect size is similar to DMSO.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay